Clinical Characterization of a Table Mounted Range Shifter Board for Synchrotron-Based Intensity Modulated Proton Therapy for Pediatric Craniospinal Irradiation

SIMPLE SUMMARY: Intensity modulated proton therapy provides unparalleled normal tissue sparing for the treatment of pediatric cancers such as medulloblastoma using craniospinal irradiation. However, proton delivery systems have a minimum deliverable energy and depth, requiring range shifter devices for the treatment of shallow targets and/or small anatomy. Standard range shifters are mounted to the treatment nozzle and introduce lateral scatter which, unfortunately, increases normal tissue dose. In this study we designed, manufactured, and characterized a range shifter board which rests directly under the patient during treatment to maintain a shallow treatment depth while minimizing lateral scatter, similar to previously proposed designs but optimized for our synchrotron-based delivery system. We present the dosimetric measurements we performed to characterize the device for treatment planning including severity of artifacts in on-board images. We compared the standard and range shifter board planning approaches in an anthropomorphic phantom and delivered the treatment plans to confirm the dosimetric differences. Finally, we compared treatment plans from two previously treated pediatric patients, demonstrating the ability to significantly reduce lung and kidney dose using this device compared to a standard range shifter. This device is now in routine use at our clinic. ABSTRACT: Purpose: To report our design, manufacturing, commissioning and initial clinical experience with a table-mounted range shifter board (RSB) intended to replace the machine-mounted range shifter (MRS) in a synchrotron-based pencil beam scanning (PBS) system to reduce penumbra and normal tissue dose for image-guided pediatric craniospinal irradiation (CSI). Methods: A custom RSB was designed and manufactured from a 3.5 cm thick slab of polymethyl methacrylate (PMMA) to be placed directly under patients, on top of our existing couch top. The relative linear stopping power (RLSP) of the RSB was measured using a multi-layer ionization chamber, and output constancy was measured using an ion chamber. End-to-end tests were performed using the MRS and RSB approaches using an anthropomorphic phantom and radiochromic film measurements. Cone beam CT (CBCT) and 2D planar kV X-ray image quality were compared with and without the RSB present using image quality phantoms. CSI plans were produced using MRS and RSB approaches for two retrospective pediatric patients, and the resultant normal tissue doses were compared. Results: The RLSP of the RSB was found to be 1.163 and provided computed penumbra of 6.9 mm in the phantom compared to 11.8 mm using the MRS. Phantom measurements using the RSB demonstrated errors in output constancy, range, and penumbra of 0.3%, −0.8%, and 0.6 mm, respectively. The RSB reduced mean kidney and lung dose compared to the MRS by 57.7% and 46.3%, respectively. The RSB decreased mean CBCT image intensities by 86.8 HU but did not significantly impact CBCT or kV spatial resolution providing acceptable image quality for patient setup. Conclusions: A custom RSB for pediatric proton CSI was designed, manufactured, modeled in our TPS, and found to significantly reduce lateral proton beam penumbra compared to a standard MRS while maintaining CBCT and kV image-quality and is in routine use at our center.